MedPath

Evaluation of the effect of extracorporeal shockwave therapy after botulinum toxin injection on cuff muscle spasticity improvement

Phase 2
Recruiting
Conditions
Multiple sclerosis.
Multiple sclerosis
Registration Number
IRCT20200825048515N41
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Definitive diagnosis of multiple sclerosis based on the opinion of a neurologist
Presence of spasticity in the cuff muscles (based on a score of more than 1 on the modified Ashworth scale (MAS)
consent to participate in the study

Exclusion Criteria

Having cognitive disorders (in advanced stages of the disease)
Having myopathy or peripheral nerve disease
Having a pace maker
Pregnancy
Pre-injection of botulinum toxin during the last 6 months
Having cuff muscle atrophy
Having coagulation disorders
History of previous surgery or fracture at the site of spastic muscles

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before, immediately, 2 weeks and 8 weeks after the intervention. Method of measurement: Visual Analogue Scale (VAS).;Spasticity score. Timepoint: Before, immediately, 2 weeks, and 8 weeks after the intervention. Method of measurement: Modified Ashworth's Scale (MAS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath